Pacer Advisors
CCXI

Pacer Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Pacer Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,351
Closed -$69K – 1594
2021
Q1 		$69K Sell
1,351
-908
-40% -$54.6K ﹤0.01% 1385
2020
Q4 		$140K Buy
2,259
+644
+40% +$36.9K ﹤0.01% 1295
2020
Q3 		$89K Buy
+1,615
New +$86.9K ﹤0.01% 1268

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacer Advisors's CCXI Position: Q2 2021 in Review

Pacer Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 1,351 shares — an estimated $69K sold.

Pacer Advisors first reported a position in CCXI in Q3 2020 and held it in 3 quarters. The position peaked at $140K in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Pacer Advisors reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 1,351 ChemoCentryx, Inc. shares in Q2 2021, an estimated $69K.
  • Pacer Advisors first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 3 quarters.
  • Pacer Advisors's ChemoCentryx, Inc. position peaked at $140K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.